Clinical Trial Update: Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer [Phase 1]

View source ↗

Summary

Phase I study of Ad5-hGCC-PADRE in Stage I/II colon cancer has completed the Phase I portion. The update summarizes safety and tolerability findings from this e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Ad5-hGCC-PADRE

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Colon Cancer | Phase 1 | Status: COMPLETED